Ingrezza OverviewValbenazine, sold under the trade name Ingrezza, is a medication use to treat tardive dyskinesia. It is being studied for Tourette's syndrome. It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor. Contents 1 Contraindications 2 Adverse effects 3 Pharmacology 3.1 Mechanism of action 4 Society and culture 4.1 Commercial aspects 4.2 Intellectual property 4.3 Names 5 See also 6 References Contraindications There are no contraindications. Adverse effe...
Read more Ingrezza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Valbenazine
Recent Ingrezza Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 40mg
NDC Database Records for Ingrezza: (1 result)Sorted by National Drug Code
- 70370-1040 Ingrezza 40 mg Oral Capsule by Neurocrine Biosciences, Inc.